Company Filing History:
Years Active: 2013
Title: Massimo Guidoboni: Innovator in Immunology
Introduction
Massimo Guidoboni is a notable inventor based in Castellina in Chianti, Italy. He has made significant contributions to the field of immunology, particularly through his innovative work on vaccines. His research focuses on the treatment of lymphoproliferative disorders, showcasing his commitment to advancing medical science.
Latest Patents
Massimo Guidoboni holds a patent for an idiotypic vaccine. This invention involves the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non-HCV-related lymphoproliferations. Specifically, it utilizes recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains obtained from patients with lymphoproliferations. This patent highlights his innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Massimo has demonstrated a strong dedication to research and development in immunology. His work has not only contributed to scientific knowledge but also has the potential to improve patient outcomes in the treatment of lymphoproliferative diseases. He is associated with Areta International S.r.l., where he continues to pursue his research interests.
Collaborations
Massimo collaborates with esteemed colleagues, including Riccardo Dolcetti and Valli De Re. These partnerships enhance the scope and impact of his research, fostering a collaborative environment that is essential for innovation in the medical field.
Conclusion
Massimo Guidoboni is a distinguished inventor whose work in immunology has the potential to transform treatment approaches for lymphoproliferative disorders. His innovative patent and collaborative efforts underscore his significant contributions to medical science.